CD147-CAR T cell therapy (Peking University People's Hospital)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCD147-CAR T cell therapy (Peking University People's Hospital)

Drug Alias Name抗CD147嵌合抗原受体T细胞疗法(北京大学人民医院)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionAnti-CD147

TargetsBasigin

Therapy Area/IndicationsLymphoma, T-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPeking University People'S Hospital

China Registration ClassN/A

Develop Information

Active CompaniesPeking University People'S Hospital

Inactive CompaniesN/A

Active IndicationsLymphoma, T-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A